240 related articles for article (PubMed ID: 25905855)
1. Racial/Ethnic and socioeconomic disparities in endocrine therapy adherence in breast cancer: a systematic review.
Roberts MC; Wheeler SB; Reeder-Hayes K
Am J Public Health; 2015 Jul; 105 Suppl 3(Suppl 3):e4-e15. PubMed ID: 25905855
[TBL] [Abstract][Full Text] [Related]
2. Geographic disparities in adherence to adjuvant endocrine therapy in Appalachian women with breast cancer.
Tan X; Camacho F; Marshall VD; Donohoe J; Anderson RT; Balkrishnan R
Res Social Adm Pharm; 2017; 13(4):796-810. PubMed ID: 27641308
[TBL] [Abstract][Full Text] [Related]
3. Racial and geographic disparities in adherence and discontinuation to adjuvant endocrine therapy in Texas Medicaid-insured patients with breast cancer.
Farias AJ; Wu WH; Du XL
Med Oncol; 2018 Jun; 35(7):113. PubMed ID: 29926275
[TBL] [Abstract][Full Text] [Related]
4. Technical report--racial and ethnic disparities in the health and health care of children.
Flores G;
Pediatrics; 2010 Apr; 125(4):e979-e1020. PubMed ID: 20351000
[TBL] [Abstract][Full Text] [Related]
5. Endocrine Therapy Nonadherence and Discontinuation in Black and White Women.
Wheeler SB; Spencer J; Pinheiro LC; Murphy CC; Earp JA; Carey L; Olshan A; Tse CK; Bell ME; Weinberger M; Reeder-Hayes KE
J Natl Cancer Inst; 2019 May; 111(5):498-508. PubMed ID: 30239824
[TBL] [Abstract][Full Text] [Related]
6. Racial/ethnic and socioeconomic disparities in the prevalence and treatment of otitis media in children in the United States.
Smith DF; Boss EF
Laryngoscope; 2010 Nov; 120(11):2306-12. PubMed ID: 20939071
[TBL] [Abstract][Full Text] [Related]
7. Adherence to adjuvant endocrine therapy for breast cancer: importance in women with low income.
Ursem CJ; Bosworth HB; Shelby RA; Hwang W; Anderson RT; Kimmick GG
J Womens Health (Larchmt); 2015 May; 24(5):403-8. PubMed ID: 25884292
[TBL] [Abstract][Full Text] [Related]
8. Adherence to adjuvant endocrine therapy among White British and ethnic minority breast cancer survivors in the United Kingdom.
McGuinness S; Hughes L; Moss-Morris R; Hunter M; Norton S; Moon Z
Eur J Cancer Care (Engl); 2022 Nov; 31(6):e13722. PubMed ID: 36255032
[TBL] [Abstract][Full Text] [Related]
9. Racial and Geographic Disparities in Endocrine Therapy Adherence Among Younger Breast Cancer Survivors.
Heiney SP; Truman S; Babatunde OA; Felder TM; Eberth JM; Crouch E; Wickersham KE; Adams SA
Am J Clin Oncol; 2020 Jul; 43(7):504-509. PubMed ID: 32251120
[TBL] [Abstract][Full Text] [Related]
10. Household net worth, racial disparities, and hormonal therapy adherence among women with early-stage breast cancer.
Hershman DL; Tsui J; Wright JD; Coromilas EJ; Tsai WY; Neugut AI
J Clin Oncol; 2015 Mar; 33(9):1053-9. PubMed ID: 25691670
[TBL] [Abstract][Full Text] [Related]
11. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005).
Harper S; Lynch J; Meersman SC; Breen N; Davis WW; Reichman MC
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):121-31. PubMed ID: 19124489
[TBL] [Abstract][Full Text] [Related]
12. Health disparities among youth with type 1 diabetes: A systematic review of the current literature.
Borschuk AP; Everhart RS
Fam Syst Health; 2015 Sep; 33(3):297-313. PubMed ID: 25984737
[TBL] [Abstract][Full Text] [Related]
13. Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review.
Lambert LK; Balneaves LG; Howard AF; Gotay CC
Breast Cancer Res Treat; 2018 Feb; 167(3):615-633. PubMed ID: 29110151
[TBL] [Abstract][Full Text] [Related]
14. Behavioral Interventions to Enhance Adherence to Hormone Therapy in Breast Cancer Survivors: A Systematic Literature Review.
Hurtado-de-Mendoza A; Cabling ML; Lobo T; Dash C; Sheppard VB
Clin Breast Cancer; 2016 Aug; 16(4):247-255.e3. PubMed ID: 27133733
[TBL] [Abstract][Full Text] [Related]
15. Depression as a predictor of adherence to adjuvant endocrine therapy (AET) in women with breast cancer: a systematic review and meta-analysis.
Mausbach BT; Schwab RB; Irwin SA
Breast Cancer Res Treat; 2015 Jul; 152(2):239-46. PubMed ID: 26077640
[TBL] [Abstract][Full Text] [Related]
16. Breast Cancer Disparities: Socioeconomic Factors versus Biology.
Newman LA
Ann Surg Oncol; 2017 Oct; 24(10):2869-2875. PubMed ID: 28766222
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing medication-taking behaviour with adjuvant endocrine therapy in women with breast cancer: A qualitative systematic review.
Xu H; Zhang XJ; Wang DQ; Xu L; Wang AP
J Adv Nurs; 2020 Feb; 76(2):445-458. PubMed ID: 31657028
[TBL] [Abstract][Full Text] [Related]
18. Psychosocial factors related to non-persistence with adjuvant endocrine therapy among women with breast cancer: the Breast Cancer Quality of Care Study (BQUAL).
Hershman DL; Kushi LH; Hillyer GC; Coromilas E; Buono D; Lamerato L; Bovbjerg DH; Mandelblatt JS; Tsai WY; Zhong X; Jacobson JS; Wright JD; Neugut AI
Breast Cancer Res Treat; 2016 May; 157(1):133-43. PubMed ID: 27086286
[TBL] [Abstract][Full Text] [Related]
19. Perceptions, Attributions, and Emotions Toward Endocrine Therapy in Young Women with Breast Cancer.
Walker HE; Rosenberg SM; Stanton AL; Petrie KJ; Partridge AH
J Adolesc Young Adult Oncol; 2016 Mar; 5(1):16-23. PubMed ID: 26812461
[TBL] [Abstract][Full Text] [Related]
20. Black women less likely to adhere to hormone therapy for breast cancer.
Printz C
Cancer; 2019 Feb; 125(3):331. PubMed ID: 30665266
[No Abstract] [Full Text] [Related]
[Next] [New Search]
